How a neuroscientist invests in biopharma

Equity analyst Laura Nelson Carney uses her PhD in neuroscience to help spot medical innovation around the world. She brings a deep understanding of science to health care investing, using her research and drug development experience to help identify breakthrough drugs. And today, she's looking beyond biotechs in Boston and San Francisco and turning her attention to China as a growing source of innovation. This content is intended to highlight issues and be of a general nature. It should not be considered advice, an endorsement or a recommendation. Products mentioned are not an offer of the product and may not be available for sale or purchase in all countries. All investments have risk, and you may lose money. Past results are not a guarantee of future results. Statements attributed to an individual represent the opinions of that individual as of the date published and do not necessarily reflect the opinions of Capital Group or its affiliates. This content is published by Capital Client Group, Inc., and copyrighted to Capital Group and affiliates, 2026, all rights reserved. For more information, including our detailed disclosures, visit For our latest insights, practice management ideas and more,

You can listen to How a neuroscientist invests in biopharma online on Radio and Podcast. Open the player on this page to stream the available audio.

How a neuroscientist invests in biopharma is an episode from Capital Ideas Investing Podcast by Capital Group.

This episode is 25:55 long.

This episode was published on Apr 16, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Capital Ideas Investing Podcast when more episodes are available from the podcast feed.